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ABSTRACT
The existence of two sophisticated parallel splicing
machineries in multicellular organisms has raised
intriguing questions—ranging from their impact on
proteome expansion to the evolution of splicing
and of metazoan genomes. Exploring roles for the
distinct splicing systems in vivo has, however, been
restricted by the lack of techniques to selectively
inhibit their function in cells. In this study, we show
that morpholino oligomers complementary to the
branch-site recognition elements of U2 or U12 small
nuclear RNA specifically suppress the function of the
two splicing systems in mammalian cells. The data
providethefirstevidenceforaroleofdistinctspliceo-
somes in pre-mRNA splicing from endogenous mam-
malian genes and establish a tool to define roles for
the different splicing machineries in vivo.
INTRODUCTION
Eukaryotic gene expression requires the removal of
non-coding gene sequences (introns) in the course of
mRNA processing. This splicing reaction is catalyzed by a
complex machinery made up of small nuclear ribonucleopro-
tein particles (snRNPs) and a large number of non-snRNP
proteins, the spliceosome [for a recent review see (1)]. snRNPs
form the catalytic core of the spliceosome and recognize
introns by short consensus sequences (splice sites) located
at the intron ends, a process that involves base-pairing with
complementary sequences in uridine-rich (U) snRNA
molecules, the RNA component of the snRNPs. Among the
ﬁve snRNPs (U1, U2, U4, U5 and U6), the U1 snRNP recog-
nizes the 50 splice site while the U2 snRNP binds to the branch
point sequence, which is close to the 30 boundary of the intron.
In the mid-1990s, non-canonical splice sites led to the
discovery of a second spliceosome in multicellular organisms.
InadditiontothecommonU5snRNP, thissecondspliceosome
contains distinct, low-abundance snRNPs (U11, U12,
U4atac and U6atac), which functionally correspond to the
U1, U2, U4 and U6 snRNPs of the classical (major class or
U2-type) splicing machinery [reviewed in (2)]. Although
evolutionarily highly conserved, only a minute proportion of
introns (e.g. 0.15–0.34% in primate and human genomes) have
been predicted to be targets for this second (minor class or
U12-type) spliceosome, based on the presence of the distinct
and highly conserved 50 splice site and branch-point sequences
(3,4). The extremely small proportion of putative substrates
and the conversion from U12-type to U2-type introns (3) have
raised the question why a sophisticated parallel splicing appar-
atus has been conserved during evolution. One answer might
be that the remaining U12-type introns have indispensable
functions in metazoan cells, e.g. in the regulation of gene
expression or in generating unique splice variants. Alternat-
ively, or in addition, there could be a wider spectrum of action
for minor spliceosomes or snRNPs than predicted. In fact,
hintsinfavor ofthelatterpossibilityhave been emerging(5,6).
An understanding of why and how metazoan genomes are
interpreted by distinct splicing systems during transcription
will require their selective inhibition in vivo. In this paper, we
report on a technique to selectively ‘knockdown’ the function
of the different splicing machineries in living cells, thereby
permitting to analyze their role in mRNA processing from
endogenous transcripts.
MATERIALS AND METHODS
Cell culture and transfections
EL4 cells were grown in DMEM and Jurkat cells in RPMI
medium; both supplemented with 10% fetal calf serum,
2 mM glutamine, 100 U ml
 1 penicillin and 100 mgm l
 1
streptomycin.
On the day before transfection, cells were plated at a density
of 8 · 10
5 cells ml
 1 and 2–3 · 10
7 cells were used for
electroporation. EL4 cells were washed once with PBS
(with Ca
2+/Mg
2+) and resuspended in 350 ml PBS (with
Ca
2+/Mg
2+)/2 mM 2-mercaptoethanol. Jurkat cells were
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doi:10.1093/nar/gni041directly resuspended in 350 ml of plain RPMI medium. After
mixing the cells with the morpholino (and 20 mg of P120
minigene plasmid for co-transfections) in a 1.5 ml polypro-
pylene reaction tube (Eppendorf) and incubation at room tem-
perature for 5–10 min, they were transferred to a 4-mm-gap
electroporation cuvette (Peqlab). Electroporation was per-
formed using a Bio-Rad Gene Pulser at 250 mF and 320 V
for EL4 cells or at 960 mF and 250 V for Jurkat cells. After
electroporation, cells were plated in 10 ml growth medium.
Electroporation conditions were determined empirically,
based on the established protocols for the transfection of plas-
mid DNA into the two cell lines. From our experience with
different lymphoma and leukemia cell lines (EL4, Jurkat and
LB17), it appears that morpholino electroporation requires no
special solutions or conditions as compared with plasmid elec-
troporation; still the transfection efﬁciency of morpholinos is
very high (80–95%, as determined by ﬂuorescein-labeled mor-
pholinos),evenifthetransfectionofplasmidDNA ismarkedly
less efﬁcient under those conditions.
Morpholino sequences
u12MO, TCGTTATTTTCCTTACTCATAAGTT (comple-
mentary to U12 nucleotides 9–33); u2MO, TGATAAGAAC-
AGATACTACACTTGA (complementary to U2 nucleotides
27–51); and cMO, CCTCTTACCTCAGTTACAATTTATA.
Morpholinos were obtained from GeneTools, Inc. (Philomath,
OR) and were dissolved in water at a concentration of
0.5 nmol ml
 1.
RT–PCR analysis
Total RNA was prepared using guanidinium isothiocyanate/
phenol (RNAPure; Peqlab). An aliquot of 0.8 mg of DNase-
treated RNA was reverse transcribed (20 ml reactions) in
MMLV-RT buffer (Promega) with 100 ng oligo-d(T)15 and
200 U MMLV-RNase-H minus reverse transcriptase
(Promega) at 42 C for 45 min.
PCRs were performed in 50 ml GoTaq-reaction buffer
(Promega) containing 5 ml of the diluted (1:10) reverse tran-
scriptase reactions, 250 mM dNTP each, 10 pmol primers and
2.5 UGoTaqDNA polymerase (Promega).A total of 28 cycles
were performed for the ampliﬁcation of P120 minigene tran-
scripts and 31 cycles for endogenous P120 and ADPRT tran-
scripts.Eachcycleconsistedof95 Cfor1min,59 C(P120)or
58 C (ADPRT) for 1 min and 72 C for 1.5 min.
Primer sequences were as follows: P120, GAAAGAAGT-
GACCCCTGAGTCAGG and CAGATCCTTCTTGAGCCG-
GTTCAG (splicing of intron F), CTGAACCGGCTCAAG-
AAGGATCTG and GTCTCGGCGTCGGGTTTTCAAGG
(splicing of intron G); ADPRT, GATCCTTCAGCTAACAT-
TAGTCTG and GCTACCTCTCCCAATTACCACAG.
RESULTS
Antisense RNA oligonucleotides to spliceosomal snRNAs,
e.g. masking those regions of U2 or U12 snRNAs comple-
mentary to the intron branch site, can selectively interfere with
assembly of the two splicing machineries in in vitro splicing
reactions using nuclear extracts and synthetic RNA substrates
(7,8). For a strategy to selectively target spliceosomal snRNAs
in living cells, we decided to use non-ionic antisense
morpholino oligomers (9). Morpholinos bind with high spe-
ciﬁcitytotranscriptsandhave beenusedtoblocksplicesites in
pre-mRNA (10,11) and mRNA translation (12,13) in vivo.T o
selectively interfere with U12- and U2-type splicing, we chose
morpholinos complementary to sequences in U12 and U2
snRNA base-pairing with the distinct branch sites of the
two splicing systems (Figure 1).
In studies using lymphoma cells, we recently found that
plain morpholinos, although being non-ionic, can be efﬁ-
ciently and cheaply transfected by electroporation, even
into cells for which electroporation of plasmid DNA is
much less efﬁcient [(14); and our unpublished
data)]. To test the potential of our morpholino oligomers
to interfere with either splicing apparatus in vivo, they
were electroporated into mouse EL4 T-lymphoma cells
together with a four-exon minigene construct derived from
the human P120 gene (15) (Figure 2A), containing U2-
dependent introns (E and G) and a U12-type intron (F).
Splicing of introns F (U12-type) and G (U2-type) from the
minigene RNA was then monitored after RT of total cellular
RNA and PCR using primers (see Figure 2A) hybridizing in
the upstream and downstream exons, respectively. Intron F
removal, reﬂected by the ampliﬁcation product lacking the
intron, was inhibited with increasing amounts of the
antisense-U12 oligomer (u12MO) co-transfected (Figure
2B, lanes 2–7). A non-speciﬁc control morpholino (cMO,
lane 8) and the antisense-U2 sequence (u2MO, lane 9), in
a concentration inhibiting U2-type splicing (cf. Figure 2C,
lane 6), had no effect. Conversely, increasing doses of the
u2MO sequence interfered with splicing of U2-dependent
intron G (Figure 2C, lanes 2–6), while the control morpholino
and the antisense-U12 morpholino in the highest amount did
not affect the removal of the intron (lanes 7 and 8). Inhibition
of U2-type splicing, however, required several-fold
higher morpholino doses (Figure 2B and C), which could
be caused by differences in the efﬁciency of morpholino
hybridization or reﬂect the high abundance of U2 snRNP
relative to U12 snRNP (16). The low abundance of the
U12-type spliceosome, together with the high levels of mini-
gene expression, may also explain the incomplete splicing of
Figure 1. Schematic representation of morpholino-mediated targeting of U12
(A) and U2 snRNA (B). U12 and U2 snRNPs with snRNA sequences base-
pairing with the corresponding branch point consensus sequence (19) in
pre-mRNA are shown (R, purine; Y, pyrimidine; and bulged A, branch site
adenosine). Antisense-morpholino (MO) oligomers to these snRNA sequences
aredepictedinred(u12MO,U12nucleotides9–33;andu2MO,U2nucleotides
27–51). Corresponding antisense RNA oligonucleotides block U12 or U2
snRNP binding to pre-mRNA in vitro (7,8). An overview on the localization
in pre-mRNA of the sequences is shown in the lower part, with exons (open
boxes) and introns [lines, with possible terminal nucleotides (19) and branch-
point adenosine, A]. For morpholino sequences, see Materials and Methods.
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relative to endogenous P120 pre-mRNA (Figure 3A and B,
upper panel, lane 2; the same result was also obtained in the
EL4 cells, data not shown). In conclusion, the ﬁndings indic-
ate selective inhibition of U2- and U12-type splicing by
delivering the corresponding antisense-morpholino sequences
to cells.
Totestthe suitabilityofthemethod foranalyzing splicingof
endogenous pre-mRNAs, we delivered the antisense-U12 oli-
gomer to the commonly used human Jurkat-leukemia cell line
by electroporation and monitored intron F removal from the
human P120 pre-mRNA at different time points after mor-
pholino transfection (Figure 3A, upper panel). While intron
removal was complete immediately after transfection (lane 2),
transcripts without intron F became almost undetectable after
6–12 h; instead, the intron-containing RNA accumulated
(lanes 2–4), indicating the suppression of intron F splicing.
The non-speciﬁc control sequence (lane 6) and the antisense-
u2MO oligomer (not shown in this panel, but see Figure 3B)
had no effect. P120 intron F represents U12-type introns hav-
ing AT and AC dinucleotides at their 50 and 30 boundaries,
respectively (15,17). As an example for an U12-type intron
with GT and AG terminal nucleotides, we examined splicing
of intron 22 of the human poly-ADP-ribosyl transferase
(ADPRT) gene (17) (Figure 3A, lower panel). Again,
transfection of the antisense-U12 morpholino blocked
original complete splicing of the intron (lane 2), and led
to the accumulation of the unspliced transcript over a
period of 18 h (lanes 2–5). The suppression of U12-type spli-
cing by the u12MO oligomer from both endogenous genes
occurred in a dose-dependent manner (Figure 3B, lanes 2–
8). Speciﬁcity is indicated by the non-speciﬁc control mor-
pholino (lane 9) and the antisense-U2 sequence (lane 10),
which did not affect intron removal. These results indicate
that the approach is effective enough for restraining spliceo-
some function on endogenous transcripts. At the same time,
they establish a role for U12 snRNA in the splicing of endo-
genous pre-mRNAs.
Figure 2. Selective inhibition of U2- and U12-type splicing in vivo.
(A) Schematic representation of human P120 minigene (15) with promoter
(open arrow), exons (open boxes) and U2- and U12-type intron sequences (E–
G, bold lines). Arrowheads indicate positions of primers used in RT–PCR.
(B and C) RT–PCR analysis of intron F (B) and intron G (C) splicing from
the P120 minigene co-transfected into murine EL4 lymphoma cells with dif-
ferent amounts (in nmol) of the morpholino (MO) oligomers indicated. RNA
was prepared 6 h after transfection. Lane 1 (-RT) corresponds to RT–PCR
showninlane2,butlackingreversetranscriptase.Amplificationproductswere
resolved by agarose gel electrophoresis and visualized by ethidium bromide
staining.M,100bpDNAladder;numbersontheleftindicatethesizeofmarker
bands (in bp). Splicing products are shown on the right-hand side as schematic
diagrams (exons, open boxes; and introns, lines). Predicted sizes for unspliced
andsplicedproductsare349and250bp(intronFsplicing),and315and171bp
(intron G splicing), respectively. Amplification reactions were not in plateau
phase as verified by fewer PCR cycles. The same results were obtained in
independent transfections followed by RT–PCR assays.
Figure 3. Inhibition of U12-type splicing from endogenous genes. (A) Antisense-U12 morpholino-mediated inhibition of splicing at different time points after
morpholino transfection. Human Jurkat-leukemia cells were transfected with 15 nmol of the u12MO or of a non-specific (cMO) morpholino oligomer. Splicing of
intronFfromP120pre-mRNA(upperpanel)andofintron22fromADPRTpre-mRNA(lowerpanel)wasanalyzedbyRT–PCRaftertheindicatedtimes.(B)Dose-
dependenceofu12MO-mediatedsplicingsuppression.MorpholinooligomersweredeliveredtoJurkatcellsintheamountsindicated(innmol),andsplicingofP120
intronFandofADPRTintron22wasanalyzed18haftertransfection.Expectedsizesforunsplicedandsplicedproductsare349and250bp(P120)and628and191bp
(ADPRT), respectively. Analysis, DNA marker and symbols are as in Figure 2. The weak band marked by the asterisk could not be obtained sufficiently pure for
unequivocal identification by sequencing, but is most probably due to cryptic splicing. Amplification reactions were not in plateau phase as verified by fewer PCR
cycles. The same results were obtained in independent transfections.
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In mammalian cells, the existence of a second spliceosome has
been established by forced co-expression of recombinant
mutated minigenes and snRNAs carrying compensatory muta-
tions (15,18). Employing snRNA as a target to block spliceo-
some function in cells, the functional ‘knockdown’ strategy
presented here proves the second spliceosome to be required
for pre-mRNA splicing from endogenous genes, and provides
a new method to explore roles for the different splicing
systems in vivo.
In keeping with a block of U12 snRNA interaction with the
branch site, as shown for corresponding antisense-U12 RNA
oligonucleotides in vitro (8), we found U12 snRNA levels
unaltered after transfection of the u12MO oligomer (data
not shown). In contrast to the highly conserved U12-type
branch-point consensus (19), metazoan U2-type branch sites
are only poorly preserved (20). Therefore, dependence of spli-
ceosome assembly on base-pairing with U2 snRNA is most
probably variable between U2-type introns. Weak base-
pairing may be compensated through the recruitment of U2
snRNP by auxiliary proteins that bind to the adjacent
polypyrimidine tract or the downstream 50 splice site
(21,22). Notably, splicing of U2-dependent intron G was
inhibited to a lesser degree by the antisense-U2 morpholino
in endogenous P120 pre-mRNA compared with P120 mini-
gene RNA (see Supplementary Figure). This could reﬂect help
in U2 snRNP recruitment to the branch point of intron G from
the downstream 50 splice site, which is not present in the
minigene construct (15). Thus, using interference with branch
site base-pairing, the U12-dependent system with its highly
conserved branch points appears to be the better target for
functionally depriving cells of one splicing machinery.
Alternatively, antisense sequences interfering with U6 or
U6atac snRNA interactions may be used, which were
shown to inhibit other steps of spliceosome assembly
in vitro (7,8).
Since several methods are now available to deliver mor-
pholino oligomers to cultured cells (for current update, see
http://www.gene-tools.com), morpholino-mediated inter-
ference with spliceosomal snRNA function should be applic-
able to many cell lines. Also, model organisms in which
morpholinos have become popular for gene ‘knockdowns’
to study embryonal development (13), including frog
(Xenopus species), chicken and zebraﬁsh, should become
accessible for the technique. Disruption of the U12 snRNA
gene by insertional mutagenesis in Drosophila was lethal very
early in embryogenesis, while an insertion generating partially
active U6atac snRNA developed till larval stages (23). In
contrast to most gene disruptions, morpholinos can phenocopy
graded series of alleles (13) that may facilitate functional
analyses. Together with techniques to introduce morpholinos
into speciﬁc populations of embryo cells (24,25), the approach
could thus provide a tool to study the role of different
splicing systems in developmental processes. Finally, cells
functionally deprived of one spliceosomal system may
provide the basis for deﬁning genome-wide spectra of
splicing events (26,27) dependent on the distinct spliceo-
somes, casting light on their role in gene expression and in
the evolution of proteome complexity in multicellular
organisms.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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